EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Evaluation of an Automated Priming Bolus for Improving Prandial Glucose Control in Full Closed Loop Delivery

Marcela Moscoso-Vasquez iD, Patricio Colmegna, Charlotte Barnett, Morgan Fuller, Chaitanya L K Koravi, Sue A Brown, Mark D DeBoer iD, Marc D Breton iD

Diabetes Technology & Therapeutics · 2025

DOI: 10.1089/dia.2024.0315 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Diabetes Technology & Therapeutics, 2025. Verfasst von Marcela Moscoso-Vasquez und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Diabetes Technology, University of Virginia, Charlottesville, Virginia, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Insulin, Hypoglycemic Agents, Blood Glucose. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Automated insulin delivery (AID) is widely available to people with type 1 diabetes (T1D), providing superior glycemic control versus traditional methods. The next generation of AID devices focus on minimizing user/device interactions, especially around meals (“full closed loop,” [FCL]). Our goal was to assess the postprandial glycemic impact of the bolus priming system (BPS), an algorithm delivering fixed insulin doses based on the likelihood of a meal having occurred, in conjunction with UVA’s latest AID.

Method

Eleven adults with T1D participated in a supervised randomized-crossover trial assessing glycemic control during two 24-h sessions with identical meals and activity—with and without BPS. On the day in-between study sessions, participants underwent food and activity challenges to test BPS safety and robustness. Continuous glucose monitor (CGM) outcomes and total insulin doses were assessed overall and following meals with potential for BPS to dose additional insulin (CGM >90 mg/dL for 1 h prior).

Results

Daytime CGM outcomes were similar with and without BPS: time-in-range (TIR) 70–180 mg/dL 70.6% [62.2–76.5] versus 65.7% [58.6%–80.6%]; time-below-range

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1InsulinHypoglycemic AgentsBlood GlucoseInsulin Infusion SystemsGlycemic ControlHumansCross-Over StudiesMaleAdultFemalePostprandial PeriodMiddle AgedBlood Glucose Self-MonitoringMealsAlgorithmsYoung Adult

Stichwörter der Autor:innen

Automated insulin deliveryAutomated priming bolusFull closed loopPostprandial glycemic controlType 1 diabetes

Substanzen

InsulinHypoglycemic AgentsBlood Glucose

Autor:innen und Institutionen

  • Center for Diabetes Technology, University of Virginia, Charlottesville, Virginia, USA.
  • Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA.
  • Department of Pediatrics, University of Virginia, Charlottesville, Virginia, USA.

ORCID-Profile: Marcela Moscoso-Vasquez, Mark D DeBoer, Marc D Breton

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Moscoso-Vasquez, M., Colmegna, P., Barnett, C., Fuller, M., Koravi, C. L. K., Brown, S. A., DeBoer, M. D., & Breton, M. D. (2025). Evaluation of an Automated Priming Bolus for Improving Prandial Glucose Control in Full Closed Loop Delivery. Diabetes Technology & Therapeutics. https://doi.org/10.1089/dia.2024.0315

Vancouver

Moscoso-Vasquez M, Colmegna P, Barnett C, Fuller M, Koravi CLK, Brown SA, et al. Evaluation of an Automated Priming Bolus for Improving Prandial Glucose Control in Full Closed Loop Delivery. Diabetes Technology & Therapeutics. 2025. doi:10.1089/dia.2024.0315

BibTeX
@article{MoscosoVasquez2025,
  author = {Moscoso-Vasquez, Marcela and Colmegna, Patricio and Barnett, Charlotte and Fuller, Morgan and Koravi, Chaitanya L K and Brown, Sue A and DeBoer, Mark D and Breton, Marc D},
  title = {Evaluation of an Automated Priming Bolus for Improving Prandial Glucose Control in Full Closed Loop Delivery},
  journal = {Diabetes Technology & Therapeutics},
  year = {2025},
  doi = {10.1089/dia.2024.0315}
}
Kostenlos starten →